Adenosine as an Adjunct to Blood Cardioplegia
A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.
Also called NCT02681913
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase
- Phase 2
- Enrolled
- 100 participants
- Sponsor
- Registry
-
NCT02681913 -
2015-001923-22
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Netherlands
- Registry status
- Unknown status
Technical summary
Registry record NCT02681913. Randomized; quadruple masking; primary purpose prevention. Start 2016-02 (registry gives no type); primary completion 2018-07 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Adenosine as an Adjunct to Blood Cardioplegia
- Condition
- Pathological Processes
- Condition
- Cardiomyopathies
- Intervention (Drug)
- Adenosine
- Lead sponsor
- Amphia Hospital
Record details
- Record id
cardio:ct-nct02681913- Content hash
1224bc0ae22279f06936543ab0046743c638441c32665f086c3d6c5fa3be19f8